跳至主要内容
临床试验/NCT00046345
NCT00046345No Longer Available不适用

Atazanavir for HIV Infected Individuals: An Early Access Program

Bristol-Myers Squibb4 个研究点 分布在 2 个国家开始时间: 2002年5月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
No Longer Available
发起方
试验地点
4

研究概览

简要总结

The purpose of this clinical research study is to provide atazanavir to patients infected with human immunodeficiency virus (HIV) whose antiviral medications are no longer working to control HIV activity within the body and who are unable to create a new treatment regimen using other available anti-HIV drugs, because of either side effects or treatment failure previously taken. The safety of this treatment will also be studied.

研究设计

研究类型
Expanded Access

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Bristol-Myers Squibb
申办方类型
Industry

研究点 (4)

Loading locations...

相似试验